The funding will be used to expand clinical partners across the U.S.
AMOpportunities is excited to announce an additional $2 million to its Series A2 from new investor Laerdal Million Lives Fund as well as current investors, PACE Healthcare Capital, OCA Ventures, and HealthX Ventures. The round is now fully subscribed and will close imminently. This brings the company’s total funding to nearly $11 million.
“We are thrilled that Laerdal Million Lives Fund is joining our Series A2 financing to complete our $2 million round," says Kyle Swinsky, CEO, AMOpportunities. “This organization has invested in incredible companies, and we’re proud to join their growing list of investments.”
The Laerdal Million Lives Fund was established in 2020 to invest in enabling technologies and platforms capable of saving lives by improving healthcare quality and education of healthcare workers. The Million Lives Fund is backed by Laerdal Medical, the world-leading provider of training, educational, and therapy products for healthcare providers, voluntary organizations, educational institutions, hospitals, and the military worldwide. They are investing $1 million and joining the Board in an observer capacity.
“AMOpportunities aligns with our mission of supporting disruptive and innovative education and learning platforms across the healthcare space,” says Jeff Trost, Managing Partner of the Million Lives Fund. “AMO is playing a meaningful role in educating the next generation of healthcare professionals—giving these learners unique access to clinical experiences and rotations that are essential to building a more robust network of clinical workers. At the Million Lives Fund, our goal of improving healthcare quality, increasing skills and proficiencies of healthcare workers globally and reducing preventable medical errors is aligned with the ROI and value propositions AMO delivers to their customers. We’re excited to invest in the company, join their Board and be a part of their future growth strategy.”
AMOpportunities will use the additional funding to continue to expand its network of U.S. hospitals and clinical partners as well as global medical schools.
The news comes on the heels of other exciting announcements from AMO, including welcoming Dr. Kevin Klauer as senior advisor for strategic partnerships; appointing Jon David Willingham to its Board of Directors; and the celebration of its 10th anniversary.
“In the past year, AMO has made tremendous strides in our work towards bridging the healthcare gap,” says Ben Bradley, COO, AMO. “This funding demonstrates the confidence our current investors, and now new additions, have in AMO as we continue to address the healthcare provider shortage.”